Suppr超能文献

内镜超声引导下细针穿刺抽吸在胰腺囊性病变诊断中的应用价值

The Utility of Endoscopic Ultrasound Fine Needle Aspiration in Pancreatic Cystic Lesions Diagnosis.

作者信息

Khoury Tawfik, Kadah Anas, Mari Amir, Sirhan Bahir, Mahamid Mahmud, Sbeit Wisam

机构信息

Department of Gastroenterology, Galilee Medical Center, Nahariya 22100, Israel.

Faculty of Medicine in the Galilee, Bar-Ilan University, Safed 1311502, Israel.

出版信息

Diagnostics (Basel). 2020 Jul 22;10(8):507. doi: 10.3390/diagnostics10080507.

Abstract

The yield of biochemical analysis of pancreatic cysts fluid obtained via fine needle aspiration (FNA) is limited. We aimed to assess whether biochemical cyst analysis correlates with the endoscopic ultra-sonographic (EUS) diagnosis. A retrospective study including patients who underwent EUS-FNA was performed. Agreement level between EUS diagnosis and biochemical analysis was reported. One-hundred-and-eleven patients were included. For cyst CEA level, 42.4% of patients with endoscopic diagnosis of pancreatic mucinous cystic neoplasm (intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasms (MCN)) had CEA level >192 ng/mL vs. 15.8% of patients who had another endoscopic diagnosis (chi square = 0.03) with poor agreement level (Kappa = 0.130). For the serous cystadenoma (SCA), the levels of amylase and CEA were defined as <250 unit/L and <5 ng/mL, respectively. Eight patients (57.1%) had amylase of <250 unit/L, while 42.9% had >250 unit/L (chi square = 0.007). The agreement level between EUS diagnosis of SCA and amylase level was poor (Kappa = 0.231). For cyst CEA level, 71.4% had CEA level <5 ng/mL vs. 28.6% who had CEA >5 ng/mL (chi square < 0.001) with fair agreement level (Kappa = 0.495). EUS-FNA for pancreatic cystic lesions poorly correlated with the EUS diagnosis. FNA should be considered in the setting of EUS worrisome findings.

摘要

通过细针穿刺抽吸(FNA)获取的胰腺囊肿液生化分析的阳性率有限。我们旨在评估生化囊肿分析与内镜超声(EUS)诊断之间是否相关。进行了一项回顾性研究,纳入接受EUS-FNA的患者。报告了EUS诊断与生化分析之间的一致性水平。共纳入111例患者。对于囊肿癌胚抗原(CEA)水平,内镜诊断为胰腺黏液性囊性肿瘤(导管内乳头状黏液性肿瘤(IPMN)和黏液性囊性肿瘤(MCN))的患者中,42.4%的患者CEA水平>192 ng/mL,而内镜诊断为其他疾病的患者中这一比例为15.8%(卡方检验=0.03),一致性水平较差(Kappa=0.130)。对于浆液性囊腺瘤(SCA),淀粉酶和CEA水平分别定义为<250单位/L和<5 ng/mL。8例患者(57.1%)的淀粉酶<250单位/L,而42.9%的患者>250单位/L(卡方检验=0.007)。EUS诊断SCA与淀粉酶水平之间的一致性水平较差(Kappa=0.231)。对于囊肿CEA水平,71.4%的患者CEA水平<5 ng/mL,而28.6%的患者CEA>5 ng/mL(卡方检验<0.001),一致性水平一般(Kappa=0.495)。胰腺囊性病变的EUS-FNA与EUS诊断相关性较差。在EUS发现可疑结果时应考虑进行FNA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cac/7460058/6feabdb9bcac/diagnostics-10-00507-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验